Q3 2024 · 13F-HR
Finepoint Capital LPholdings as filed
Filed 2024-11-13 · accession 0000904454-24-000600
$1.38B
Reported value
26
Positions
2024-09-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 82846H405 | QXO | QXO INC | $406.1M | 29.5% | 25,750,781 | Common | SOLE |
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $318.4M | 23.1% | 555,000 | PUT | SOLE |
| 464287655 | IWM | ISHARES TR | $235.2M | 17.1% | 1,065,000 | PUT | SOLE |
| 530307305 | LBRDK | Liberty Broadband Corp | $154.2M | 11.2% | 1,994,510 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $33.2M | 2.41% | 731,960 | Common | SOLE |
| 04016X101 | ARGX | Argenx SE | $29.5M | 2.14% | 54,428 | Common | SOLE |
| 04351P101 | ASNDUSD | ASCENDIS PHARMA A/S | $28.4M | 2.06% | 190,072 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $24.9M | 1.81% | 1,782,267 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $20.9M | 1.52% | 650,852 | Common | SOLE |
| 61559X104 | MLTX | MoonLake Immunotherapeutics | $19.6M | 1.42% | 388,835 | Common | SOLE |
| 803607100 | SRPT | SAREPTA THERAPEUTICS INC | $16.7M | 1.21% | 133,535 | Common | SOLE |
| 36315X101 | LKFT | GALAPAGOS NV | $16.1M | 1.17% | 557,762 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $14.1M | 1.03% | 574,378 | Common | SOLE |
| 004225108 | ACAD | ACADIA PHARMACEUTICALS INC | $13.9M | 1.01% | 905,384 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $13.5M | 0.98% | 256,449 | Common | SOLE |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $11.5M | 0.84% | 1,626,146 | Common | SOLE |
| G72800108 | PRTA | PROTHENA CORP PLC | $7.3M | 0.53% | 433,471 | Common | SOLE |
| 83422E204 | SLDB | SOLID BIOSCIENCES INC | $6.7M | 0.49% | 961,251 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $5.7M | 0.41% | 707,404 | Common | SOLE |
| G63836111 | IVCPW | Swiftmerge Acquisition Corp | $39,200 | 0.00% | 490,000 | Common | SOLE |
| G2476C123 | CDAWF | Compass Digital Acquisition Corp | $28,054 | 0.00% | 459,906 | Common | SOLE |
| G6202B119 | MNYWW | MONEYHERO LIMITED | $26,850 | 0.00% | 895,000 | Common | SOLE |
| 56608A113 | — | Marblegate Acquisition Corp | $25,284 | 0.00% | 735,000 | Common | SOLE |
| G9845F117 | LSBWF | LAKESHORE BIOPHARMA CO LTD | $24,206 | 0.00% | 489,999 | Common | SOLE |
| 320703309 | — | CALIDI BIOTHERAPEUTICS INC | $14,249 | 0.00% | 12,500 | Common | SOLE |
| 320703119 | CLDWW | CALIDI BIOTHERAPEUTICS INC | $8,583 | 0.00% | 655,200 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.